<?xml version="1.0" encoding="UTF-8"?>
<ref id="B13-vaccines-08-00328">
 <label>13.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Yun</surname>
    <given-names>K.W.</given-names>
   </name>
   <name>
    <surname>Lee</surname>
    <given-names>H.J.</given-names>
   </name>
   <name>
    <surname>Kang</surname>
    <given-names>J.H.</given-names>
   </name>
   <name>
    <surname>Eun</surname>
    <given-names>B.W.</given-names>
   </name>
   <name>
    <surname>Kim</surname>
    <given-names>Y.J.</given-names>
   </name>
   <name>
    <surname>Kim</surname>
    <given-names>K.H.</given-names>
   </name>
   <name>
    <surname>Kim</surname>
    <given-names>N.H.</given-names>
   </name>
   <name>
    <surname>Hong</surname>
    <given-names>Y.J.</given-names>
   </name>
   <name>
    <surname>Kim</surname>
    <given-names>D.H.</given-names>
   </name>
   <name>
    <surname>Kim</surname>
    <given-names>H.M.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Safety and immunogenicity of a freeze-dried, Vero cell culture-derived, inactivated Japanese encephalitis vaccine (KD-287, ENCEVACÂ®) versus a mouse brain-derived inactivated Japanese encephalitis vaccine in children: A phase III, multicenter, double-blinded, randomized trial</article-title>
  <source>BMC Infect. Dis.</source>
  <year>2015</year>
  <volume>8</volume>
  <elocation-id>7</elocation-id>
 </element-citation>
</ref>
